Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)

Auteurs

Emmanuelle Samalin, Christelle de la Fouchardière, Simon Thézenas, Valérie Boige, Hélène Senellart, Rosine Guimbaud, Julien Taïeb, Eric François, Marie-Pierre Galais, Astrid Lièvre, Jean-François Seitz, Jean-Philippe Metges, Olivier Bouché, Florence Boissière-Michot, Evelyne Lopez-Crapez, Frédéric Bibeau, Alexandre Ho-Pun-Cheung, Marc Ychou, Antoine Adenis, Frédéric Di Fiore, Thibault Mazard